Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

NCT04374877 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Clear Cell Renal Cell Carcinoma
Hepatocellular Carcinoma
Non-small Cell Lung Cancer

Interventions

DRUG: CHS-388
DRUG: Pembrolizumab
DRUG: Toripalimab

Sponsor

Coherus Oncology, Inc.

Collaborators

[object Object]